Key result
Adiponectin gene polymorphisms G-11391A and T45G were associated with an increased 3-year risk of developing hyperglycemia.
Why the study?
Do adiponectin gene polymorphisms and baseline adiponectin levels predict the development of hyperglycemia in normoglycemic subjects?
Cohort (n=4,500)
Do adiponectin gene polymorphisms and baseline adiponectin levels predict the development of hyperglycemia in normoglycemic subjects?
Adiponectin gene polymorphisms (G-11391A and T45G) and baseline adiponectin levels independently predict the onset of hyperglycemia and changes in body fat distribution over 3 years in a French Caucasian cohort.
Answers are grounded in this paper and cite their sources.
May flag higher hyperglycemia risk in normoglycemic adults; hypothesis-generating and requires prospective validation before clinical use.
The plasma concentration of the adipocyte-derived peptide adiponectin is decreased in patients with obesity and type 2 diabetes. The adiponectin gene is located on chromosome 3q27, where a diabetes susceptibility locus has been mapped. Adiponectin gene polymorphisms (single nucleotide polymorphisms [SNPs]) have been associated with BMI, insulin sensitivity, and type 2 diabetes in some cross-sectional studies. Our aim was to assess the contribution of these SNPs in the development of features of the insulin resistance syndrome in a 3-year prospective study in approximately 4,500 French Caucasian subjects from the Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) cohort. For subjects who were normoglycemic at baseline, the 3-year risk of becoming hyperglycemic (diabetes or impaired fasting glucose) was affected by two SNPs: G-11391A and T45G. For G-11391A, the risk was increased in GA carriers (odds ratio [OR] adjusted for sex [versus GG] = 1.60 [95% CI 1.16-2.20]; P = 0.004). For T45G, it was increased in GG carriers (OR [versus TT] = 2.71 [1.31-5.60]; P = 0.007). After 3 years, GG subjects had a greater increase in BMI (P = 0.009) and waist-to-hip ratio (P = 0.007). Adiponectin levels at baseline were associated with the development of hyperglycemia (P = 0.005), but the predictive effects on the risk for hyperglycemia were independent of adiponectin genotypes. In conclusion, in the DESIR study, variations at the adiponectin locus affect body weight gain, body fat distribution, and onset of hyperglycemia, as well as adiponectin levels. Adiponectin gene SNPs may have several phenotypic effects that co-occur with the development of the metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Fumeron et al. (2004) conducted a cohort in Normoglycemia at baseline (n=4,500). Adiponectin gene polymorphisms (G-11391A and T45G) vs. GG carriers (for G-11391A) and TT carriers (for T45G) was evaluated on Development of hyperglycemia (diabetes or impaired fasting glucose) (OR 2.71, 95% CI 1.31-5.60, p=0.007). Adiponectin gene polymorphisms G-11391A and T45G were associated with an increased 3-year risk of developing hyperglycemia.
Synapse has enriched 10 related papers. Consider them for comparative context: